Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Heimburger

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
American Journal of Nephrology|December 17, 2008
N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patientsQunying Guo, Peter Bárány, Abdul Rashid Qureshi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2004
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapyMohamed E Suliman, Peter Stenvinkel, A Rashid Qureshi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 7, 2010
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?Hannes Olauson, Abdul Rashid Qureshi, Tetsu Miyamoto, et al.
The American Journal of Clinical Nutrition|September 8, 2007
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortalityHirokazu Honda, Abdul Rashid Qureshi, Jonas Axelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemiaFrancesco Locatelli, Jorge B Cannata-Andía, Tilman B Drüeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Nutritional status in dialysis patients: a European consensusFrancesco Locatelli, Denis Fouque, Olof Heimburger, et al.
Kidney International|May 16, 2012
European guidelines on when to start dialysis: check the facts first before commentingWim Van Biesen, Friedo Dekker, Olof Heimburger, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 24, 2015
Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis PatientsNaohito Isoyama, Anna Machowska, Abdul Rashid Qureshi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2014
Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patientsNaohito Isoyama, Paul Leurs, Abdul Rashid Qureshi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2012
Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patientsChristiaan L Meuwese, Friedo W Dekker, Bengt Lindholm, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
American Journal of Nephrology|December 17, 2008
N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patientsQunying Guo, Peter Bárány, Abdul Rashid Qureshi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2004
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapyMohamed E Suliman, Peter Stenvinkel, A Rashid Qureshi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 7, 2010
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?Hannes Olauson, Abdul Rashid Qureshi, Tetsu Miyamoto, et al.
The American Journal of Clinical Nutrition|September 8, 2007
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortalityHirokazu Honda, Abdul Rashid Qureshi, Jonas Axelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemiaFrancesco Locatelli, Jorge B Cannata-Andía, Tilman B Drüeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Nutritional status in dialysis patients: a European consensusFrancesco Locatelli, Denis Fouque, Olof Heimburger, et al.
Kidney International|May 16, 2012
European guidelines on when to start dialysis: check the facts first before commentingWim Van Biesen, Friedo Dekker, Olof Heimburger, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 24, 2015
Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis PatientsNaohito Isoyama, Anna Machowska, Abdul Rashid Qureshi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2014
Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patientsNaohito Isoyama, Paul Leurs, Abdul Rashid Qureshi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2012
Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patientsChristiaan L Meuwese, Friedo W Dekker, Bengt Lindholm, et al.
Pageof 6